Hospital Universitario Araba — Clinical Trial Site

49 Registered trials

16 Currently recruiting

Organisation

Hospital Universitario Araba

Location

Vitoria, Spain

Identifier

ORG-100039644

Address

Jose Atxotegui S/n, 09010, Spain

Departments

#2311:servicio de neurología
#3414 - Reumatología
#40863: Reumatología
3414: Reumatología
7106: Hematología
Digestivo
Functional sleep unit
Funtional sleep unit
Hematología
Hematology
infectious diseases
Internal Medicine
Medicina Interna - Sección de Enfermedades Infecciosas
Oncología
Oncology
Oncology Service
Pediatria
Pediatric
Pediatric Endocrinology
Pediatrics Endocrinology
Psychiatry
reumatologia
Rheumatology
Servicio de endocrinologia y pediatria
Servicio de Reumatología
Servicio de Reumatología -Sede Txagorritxu
Servicio de Traumatología y Cirugía Ortopédica
Sleep Unit
Unidad de Ensayos clínicos
Unidad del Sueño
Urología
Urology

Clinical trials at this site (49)

Search interface

A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Tr… Not authorised

2025-523820-26-00 Growth Hormone Deficiency (GHD) 5
Utility of the use of N-acetylcisteine associated with conventional treatment in patients with severe acute alcoholic hepatitis (Maddrey>=32… Pending

2023-510163-35-00 Acute Alcoholic hepatitis 5
A randomized, double blind, double dummy, parallel group, multicenter clinical trial to evaluate the safety and clinical and microbiologic e… Pending

2024-518646-24-00 Uncomplicated urinary tract infection (uUTI) 11
Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with … Pending

2025-521086-28-00 CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arth 6
A Phase 3, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Subjects with Active Pso… Pending

2025-522586-30-00 Psoriatic Arthritis 5
Clinical Study to Evaluate the Effects of Cevostamab in Patients with Lupus with or without Active Lupus Nephritis Pending

2025-522904-26-00 Systemic Lupus Erythematosus (SLE) With or Without Acti 3
A study to evaluate the efficacy and safety of belantamab mafodotin in combination with standard of care in participants aged 18 years and o… Pending

2025-523117-28-00 Relapsed or Refractory Multiple Myeloma 4
A study to test whether different doses of BI 3000202 help people with systemic lupus erythematosus (SLE) Pending

2025-523488-39-00 Systemic lupus erythematosus 4
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 Pending

2025-523911-13-00 Narcolepsy Type 1 5
A Phase 3 Single-arm Study of UGN-104 for the Treatment of LG-UTUC Recruiting

2024-519343-15-00 Low-grade Upper Tract Urothelial Cancer 5 2025-10-08
A study to find how well Dazodalibep works and how safe it is in participants with Sjôgren`s Syndrome Recruiting

2023-503904-10-00 Sjögren’s Syndrome With Moderate-to-severe Systemic Dis 5 2024-06-07
Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants with HPP Recruiting

2023-505675-73-00 hypophosphatasia 5 2024-04-26
Study to evaluate the efficacy and safety of supportive mitomycin C administered via electric current in the treatment of non-muscle invasiv… Recruiting

2024-520006-19-00 Non-muscle invasive bladder cancer 6 2021-12-15
CLINICAL TRIAL TO EVALUATE BLADDER INSTILLATION OF NEOADJUVANT CHEMOTHERAPY TO TRANSURETHRAL RESECTION OF THE BLADDER FOR THE PREVENTION OF … Recruiting

2024-512683-53-00 Non-muscle invasive bladder cancer 6 2018-05-18
A Long-term Extension Study of ORX750 in Participants with Narcolepsy and Idiopathic Hypersomnia Recruiting

2025-522987-34-00 Narcolepsy and Idiopathic Hypersomnia 4 2026-03-13
Phase Ib-II, non-randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with modFOLFIRINOX for front-line trea… Recruiting

2024-511459-16-00 Histologically confirmed pancreatic adenocarcinoma with 9 2025-10-14
A Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects with Active Psoriatic Arthritis Stratified by Prior… Recruiting

2024-513112-99-00 Active Psoriatic Arthritis Stratified by Prior Biologic 5 2025-06-13
A Study of ORX750 in Subjects with Narcolepsy and Idiopathic Hypersomnia Recruiting

2024-518929-15-00 Narcolepsy and Idiopathic Hypersomnia 4 2025-06-09
A Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 in Participants with IH Recruiting

2024-517712-29-00 Idiopathic Hypersomnia (IH) 4 2025-05-27
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis (SchizOMICS) Recruiting

2024-516768-28-00 Schizophrenia 6 2024-12-16
A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting

2023-508191-11-00 Systemic lupus erythematosus (SLE) 5 2024-11-28
Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting

2024-511719-40-00 Enterococcus faecalis infectious endocarditis 6 2024-10-09
Phase 3 extension study to evaluate long-term safety of two regimens of ianalumab in participants with systemic lupus erythematosus (SIRIUS-… Recruiting

2023-505929-14-00 Systemic Lupus Erythematosus 5 2024-05-21
Frexalimab in preservation of endogenous insulin secretion compared to placebo in adults, adolescents and children on top of Insulin therapy… Recruiting

2022-500531-36-00 Type 1 diabetes mellitus 4 2024-02-02